Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Tubercidin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

pembrolizumab 640 Specimen Handling 601 Magnetic Resonance Spectroscopy 511 Carboplatin 431 Cyclophosphamide 397 Cisplatin 361 Biopsy 349 Nivolumab 311 Paclitaxel 307 Gemcitabine 293 Radiotherapy 254 Bevacizumab 239 fludarabine 219 Dexamethasone 214 venetoclax 204 durvalumab 185 Oxaliplatin 185 Docetaxel 185 Pemetrexed 176 Fluorouracil 174 Rituximab 173 atezolizumab 172 Doxorubicin 163 Capecitabine 161 Radiation 153 Ipilimumab 146 Radiosurgery 145 Prednisone 138 Leucovorin 137 Standard of Care 131

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡